Cover Image

Ceronco Biosciences - 產品平台分析

Ceronco Biosciences - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 351252
出版日期 內容資訊 英文 19 Pages
Back to Top
Ceronco Biosciences - 產品平台分析 Ceronco Biosciences - Product Pipeline Review - 2015
出版日期: 2015年12月30日 內容資訊: 英文 19 Pages



Ceronco Biosciences是正在開發基於短鏈鞘脂技術之新癌症治療藥的荷蘭製藥企業。以腫瘤的細胞膜為標的,實現了讓藥物可流入腫瘤細胞內。目前前臨床階段的產品對象疾病有軟組織肉瘤,卵巢癌症,兒童的急性淋巴性白血病及胰臟癌症。

本報告提供Ceronco Biosciences 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。


Ceronco Biosciences 基本資料

  • Ceronco Biosciences 概要
  • 主要資訊
  • 企業資料

Ceronco Biosciences :R&D概要

  • 主要的治療範圍

Ceronco Biosciences :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Ceronco Biosciences :開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Ceronco Biosciences :藥物簡介

  • doxorubicin
  • mitoxantrone hydrochloride
  • vinorelbine tartrate

Ceronco Biosciences :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Ceronco Biosciences :總公司和子公司的所在地

  • 總公司



Product Code: GMDHC07942CDB


Global Markets Direct's, 'Ceronco Biosciences - Product Pipeline Review - 2015', provides an overview of the Ceronco Biosciences's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ceronco Biosciences's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


  • The report provides brief overview of Ceronco Biosciences including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Ceronco Biosciences's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Ceronco Biosciences's pipeline products

Reasons to buy

  • Evaluate Ceronco Biosciences's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Ceronco Biosciences in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Ceronco Biosciences's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Ceronco Biosciences and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ceronco Biosciences
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Ceronco Biosciences and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Ceronco Biosciences Snapshot
    • Ceronco Biosciences Overview
    • Key Information
    • Key Facts
  • Ceronco Biosciences - Research and Development Overview
    • Key Therapeutic Areas
  • Ceronco Biosciences - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Ceronco Biosciences - Pipeline Products Glance
    • Ceronco Biosciences - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Ceronco Biosciences - Drug Profiles
    • doxorubicin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • mitoxantrone hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • vinorelbine tartrate
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Ceronco Biosciences - Pipeline Analysis
  • Ceronco Biosciences - Pipeline Products by Target
  • Ceronco Biosciences - Pipeline Products by Molecule Type
  • Ceronco Biosciences - Pipeline Products by Mechanism of Action
  • Ceronco Biosciences - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Ceronco Biosciences, Key Information
  • Ceronco Biosciences, Key Facts
  • Ceronco Biosciences - Pipeline by Indication, 2015
  • Ceronco Biosciences - Pipeline by Stage of Development, 2015
  • Ceronco Biosciences - Monotherapy Products in Pipeline, 2015
  • Ceronco Biosciences - Preclinical, 2015
  • Ceronco Biosciences - Pipeline by Target, 2015
  • Ceronco Biosciences - Pipeline by Molecule Type, 2015
  • Ceronco Biosciences - Pipeline Products by Mechanism of Action, 2015

List of Figures

  • Ceronco Biosciences - Pipeline by Top 10 Indication, 2015
  • Ceronco Biosciences - Pipeline by Top 10 Target, 2015
  • Ceronco Biosciences - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top